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Spectrin from human erythrocytes binds to bilayer dispersions of both DMPC and DMPSDMPC (I: 1, w/w). However, 
no effect of bound spectrin on the conformation of the lipid head groups, as measured from the deuterium quadrupolar 
splittings of DMPC or DMPS specifically deuterated in the polar head groups, was detected in I:1 mixtures of the two 
lipids containing either deuterated DMPC or DMPS. Neither the phase transition of the DMPS:DMPC mixtures, nor 
the spin-lattice relaxation time (T,) of the deuterated DMPS head group, was affected by spectrin. These results argue 
against any strong interaction of spectrin with phosphatidylserine and rule out the possibility that spectrin is responsible 
for the maintainance of PS in the inner monolayer of the erythrocyte membrane during the whole life-span of this cell. 
Spectrin; Phosphatidylserine; Phosphatidylcholine; NMR, 2H-; NMR, 31P- 
1. INTRODUCTION 
It has been proposed that the interaction be- 
tween spectrin [l] and phosphatidylserine is suffi- 
cient to maintain the asymmetric distribution of 
phosphatidylserine across the erythrocyte mem- 
brane [2,3]. More recently, an ATP-dependent 
translocation of aminophospholipids from the 
outer to the inner leaflet of the erythrocyte mem- 
brane, catalysed by a specific membrane protein, 
has been demonstrated using spin-labeled probes 
[4-61 and confirmed by other methods [7-9). The 
asymmetric distribution of aminophospholipids 
was accordingly accounted for by a dynamic 
equilibrium between outside-inside transport and 
inside-outside diffusion [lo]. It was suggested that 
a strong spectrin-phosphatidylserine interaction 
might still play a role in slowing down the inside- 
outside diffusion of aminophospholipids which 
would otherwise be as fast as the outside-inside 
transport [11,12]. The involvement of spectrin in 
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maintaining transmembrane phospholipid asym- 
metry was supported by evidence for a specific 
electrostatic binding between spectrin dimers and 
phosphatidylserine monolayers [ 131 or bilayers 
[ 14,151. Despite evidence for a specificity in the in- 
teraction of spectrin with phosphatidylserine, a re- 
cent study has shown that the interaction energy is 
lower than the thermal energy at room temperature 
[ 171. It has also been suggested that the affinity of 
spectrin for PS vesicles is not significantly dif- 
ferent from its affinity for phosphatidylcholine 
vesicles [16]. In view of these disagreements, it
seemed important to obtain new data about the 
possible specificity of PS-spectrin interaction. We 
report here a deuterium nuclear magnetic 
resonance study of the interaction between spectrin 
purified from human erythrocyte and bilayers of 
mixed dimyristoylphosphatidylserine (DMPS) and 
dimyristoylphosphatidylcholine (DMPC), where 
either DMPS or DMPC is deuterated in the polar 
head group. 
Deuterium NMR has been shown to be a sen- 
sitive method to study the interaction between 
head group deuterated phospholipids, such as 
phosphatidylserine and a variety of membrane 
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proteins including peripheral membrane proteins 
[I 81, polymixin [ 191, cytochrome c [20], short 
charged artificial peptides [21] and bee venom 
melittin [22]. 
2. MATERIALS AND METHODS 
2.1. Spectrin 
Spectrin dimers from human erythrocytes were prepared as 
indicated in [23]. Their purity was confirmed by SDS-gel elec- 
trophoresis using the buffer system of Laemmli [24]. Spectrin 
was finally dialysed overnight against 100 mM Tris-HCl, 1 mM 
EDTA, pH 7.3. 
2.2. Lipids 
The head group deuterated phospholipid ofi-deuterated 
DMPS (DMPSds) was synthesized as described in [25], and Cup- 
deuterated DMPC (DMPC-&) and y-deuterated DMPC 
(DMPC-$) were prepared as indicated in [26]. DMPC was pur- 
chased from Fluka. DMPS was prepared as indicated in [27]. 
All lipids were homogeneous by silica gel TLC. 
2.3. Sample preparation 
Samples for NMR experiments were prepared by mixing 
stock solutions of each lipid in chloroform/methanol/water 
(65 : 25 : 4, v/v) to give the desired composition. The solvent was 
removed in a stream of dry nitrogen at 40°C and the lipid mix- 
tures dried under high vacuum overnight, and fully hydrated at 
40°C with an excess of 100 mM Tris-HCl, 1 mM EDTA buffer, 
pH 7.3, containing various concentrations of spectrin dimers, 
from 0 to 1 mM. The lipid vesicles were ultracentrifuged 
(120000 x g; 50 min; 10°C) and the amount of bound protein 
was determined by measuring the absorbance of the superna- 
tant at 280 nm. The pellet was then washed once with the same 
buffer prepared in deuterium-depleted water. Ultracentrifuga- 
tion and measurement of the optical density of the supernatant 
were repeated to determine the final amount of bound protein. 
The final concentration of lipids in the pellet used for NMR 
measurements was 50-100 mg/ml. 
2.4. Binding experiments 
Dried lipid mixtures of either 0.5 mg DMPS + 0.5 mg 
DMPC, or 1 mg of pure DMPC were prepared as described 
above. These were hydrated and vortexed at 40°C with 1 ml of 
spectrin solution at various concentrations. The lipid suspen- 
sions were centrifuged (120000 x g; 50 min; 10°C) and the ab- 
sorbance of the supernatant was measured at 280 nm to 
determine the amount of bound spectrin. 
2.5. ‘H and 3’P NMR spectroscopy 
NMR spectra were recorded on a Nicolet 360 MHz spec- 
trometer operating at 55.3 MHz for ‘H and at 145.1 MHz for 
“P. Single 90” pulses were used (14 ps for ‘H and 9 ps for “P). 
For *H NMR spectra, typically 20000-50000 transients were 
accumulated with a repetition time ranging between 50 (for 
DMPS-dj) and 150 ms (for DMPC-d/d,). Deuterium spin- 
lattice relaxation times (Tr) were measured by using an 
inversion-recovery pulse sequence. Temperatures were controll- 
ed with a thermostated gas flow unit and were accurate to 
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within 2°C as determined by calibration against the pure 
DMPC phase transition. 
3. RESULTS 
3.1. Binding experiments 
Fig.1 shows the amount of lipid-bound spectrin 
as a function of the total amount of protein in the 
suspension for either pure DMPC or 
DMPC : DMPS (1: 1) suspensions. A binding con- 
stant K, E 10’ M-’ is obtained for both lipid 
preparations with no significant difference be- 
tween them. The number of sites for PS or PC on 
each spectrin molecule is n z 104. 
3.2. “P NMR experiments 
DMPC : DMPS (1: 1) dispersions exhibit 
phosphorus-3 1 NMR spectra characteristic of par- 
tial membrane orientation (increased 90” orienta- 
tional component of the powder pattern) (fig.2a). 
This spectrum contains a narrow line, which may 
be due to the presence of small vesicles. The addi- 
tion of spectrin results in a phosphorus-31 powder 
pattern more characteristic of a spherical distribu- 
tion of orientational components typical of 
unoriented bilayers (fig.2b). 
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Fig. 1. Binding of spectrin dimers to liposomes as a function of 
the amount of protein in the dispersion (1 ml volume). DMPC 
(1 mg) (A); DMPS:DMPC (0.5:O.S mg) (0). 
Volume 244, number 1 FEBS LETTERS February 1989 
I I “‘I I I I’1 
10000 0 -10000 
Iii 
Fig.2. Phosphorus-3 1 NMR spectra of DMPC : DMPS 
dispersions (1: 1, w/w; 20 mg total lipid in 0.3 ml; 35°C) either 
in the absence (a) or in the presence (b) of 4.5 mg of bound 
spectrin. 
3.3. ‘H NMR experiments 
Deuterium NMR spectra at 35°C of head group 
deuterated DMPC mixed with equimolar DMPS 
Fig.3. Deuterium NMR spectra of DMPC-d,: DMPC- Fig.4. Deuterium NMR spectra of DMPC:DMPS-d3 
&: DMPS dispersions (I :9: 10; w/w; 20 mg total lipid in dispersions (1: 1, w/w; 20 mg total lipid in 0.3 ml; 35°C) either 
0.3 ml; 35°C) either in the absence (a) or in the presence (b) of in the absence (a) or in the presence (b) of 4.5 mg of bound 
2.4 mg of bound spectrin. spectrin. 
are shown in fig.3. The head group deuterated 
DMPC is a mixture of DMPC-& and DMPC-ds 
(9: 1, w/w). The spectrum from the protein-free 
dispersions (fig.3a) shows three distinct 
quadrupolar splittings, the internal one (0.8 kHz) 
corresponding to the deuterons of the N(CD+ 
groups of DMPC-ds, the intermediate splitting 
(2.4 kHz) from the deuterons in &positions of 
DMPC-&, while the largest splittings partially 
resolved into two splittings (7.8 and 8.6 kHz) cor- 
respond to the two deuterons in cY-position of 
DMPC-& [28]. The magnitude of these splittings 
is unaffected by bound spectrin (fig.3b) although 
the spectral lines are narrower in the presence of 
spectrin. 
Deuterium NMR spectra at 35°C of head group 
deuterated DMPS-d3 mixed with DMPC (1: 1, 
w/w) (fig.4a) show three resolved quadrupolar 
splittings, the two inner ones (2.8 and 9.7 kHz, 
respectively) corresponding to the deuterons in the 
a-position of the serine head group, and the larger 
one (14 kHz) corresponding to the deuteron in ,& 
position [28]. Again, there is no observable effect 
of the incorporation of spectrin on the magnitude 
of these splittings (fig.4b). 
However, alteration of lineshape is observed. In- 
deed, the spectrum of pure lipids displays sharp 
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edge lines and no observable external shoulders, 
whereas incorporation of spectrin yields shorter 
edges and enhanced shoulders. This result is in 
good agreement with 31P experiments. 
The temperature dependence of the deuterium 
quadrupole splittings of DMPSd3 in DMPC- 
DMPS-d3 dispersions with and without spectrin 
(23 wt%) is shown in fig.5. The gel-liquid 
crystalline phase transition for these dispersions 
occurs at about 24°C for both pure lipid and 
spectrin-containing complexes. The deuterium 
spin-lattice relaxation times (Ti) for the DMPS-d3 
deuterons in these dispersions (6.7 + 0.5 ms for the 
cu-deuterons; 8.6 k 0.5 ms for the &deuteron at 
35°C) were also unaffected by the presence of 
spectrin. 
4. DISCUSSION 
The lack of specificity in the binding of spectrin 
to phosphatidylserine compared with phosphati- 
dylcholine (fig.1) is in agreement with previous 
work [13,16,29]. The high-binding constant 
(lo7 M-‘) is to be interpreted in view of the high 
number of sites per molecule of spectrin (104). This 
number itself is in reasonable agreement with mea- 
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Fig.5. Quadrupole splittings from head group deuterated 
DMPS-d3 in mixed bilayers with DMPC (1: 1, w/w; 20 mg total 
lipid in 0.3 ml) as a function of temperature, in the absence 
(0, A , n ) and in the presence (0, A , q ) of 4.5 mg of bound 
spectrin. 
surements performed (on PS) by other methods 
[ 141. The binding data also demonstrate that a 
large amount of spectrin (up to 23 wt% relative to 
lipid) is bound to the mixed lipid dispersions for 
which NMB data were obtained. It has been shown 
that the measured quadrupole splittings of head 
group deuterated phospholipids are sensitive to 
structural perturbations of the membrane surface 
[36,43,44]. Thus, the absence of any effect of 
bound spectrin on the quadrupolar splittings and 
Ti relaxation times indicates that no significant 
change in the DMPS-d3 conformation or dynamics 
of the DMPS head group are induced by the pro- 
tein, even with a large amount of spectrin 
(23 wt% = 0.39 x 10m3 mol%) that is similar to 
the physiological spectrin-lipid ratio (1O-3 mol%) 
[7] in the inner leaflet of the erythrocyte mem- 
brane. This result can be compared with other 
deuterium NMR studies of the interaction between 
PS and various proteins [20-22,301, which show 
that positively charged proteins which do not 
penetrate within the bilayer have detectable 
(though weak) effects on the conformation of PS 
head group [20,21]. Proteins which are both charg- 
ed and able to penetrate into the membrane surface 
have a much larger effect on the conformation of 
PS head group [30]. The absence of any effect of 
spectrin on the conformation of PS head group 
suggests that the interaction of spectrin with these 
lipids is purely superficial and has no hydrophobic 
component, despite the presence of some 
hydrophobic segments on the protein [31]. Spec- 
trin has an overall negative charge [32] above its 
isoelectric point of 5.6 [33]. Direct association with 
negatively charged lipids above pH 6.5 [2] may 
take place through orientation of positively charg- 
ed segments of spectrin towards the polar moiety 
of the lipids [7]. 
Due to the relatively narrow frequency band of 
the spectrometer, we cannot rule out the possibility 
that part of the signal was transformed into a 
broad undetectable spectral component from im- 
mobilized lipid head groups bound to spectrin. 
Such an immobilization is unlikely because no loss 
of spectral intensity was observed between protein- 
free and spectrin-containing complexes and also 
from the lack of effect of spectrin on the 
quadrupole splittings of head group deuterated 
DMPC (DMPC-dd/d,) in DMPC:DMPS mix- 
tures. The DMPC head group splittings are sen- 
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sitive to the presence of DMPS [26] and any loss of 
DMPS from the mixed lipid phase by binding to 
spectrin would be expected to be reflected in a 
decreased PS-induced perturbation of the DMPC 
head group quadrupole splittings [ 19,221. 
Moreover, it has been shown that fluorescent 
labeled phosphatidylserine has a faster lateral dif- 
fusion on the inner face of the erythrocyte mem- 
brane where spectrin is present, than on the outer 
face [35], with no detectable immobilized com- 
ponent .
transition does not therefore imply a specificity of 
the mode of interaction between DMPS and 
spectrin. 
The absence of any effect of spectrin on the 
quadrupolar splittings of DMPC deuterated in the 
head group, in 1: 1 mixtures with DMPS, provides 
further evidence of the nature of spectrin/lipid in- 
teractions. The presence of charged lipids such as 
DMPS [28], of ions [36] or of charged anaesthetics 
[37] near the deuterated head group of DMPC 
strongly modifies its conformation, as a result of 
the perturbation of the bilayer surface charge [43]. 
Partial neutralization or screening of DMPS 
charges by positive charges at the membrane sur- 
face allows the DMPC head group to recover its 
original conformation [22]. Neutralization of the 
surface potential resulting from DMPS negative 
charges, by segmental positive charges on spectrin, 
thus seems to be precluded by our negative result. 
It is more likely that a dipolar interaction between 
spectrin and the lipid/water interface, occurs, and 
that this type of interaction accounts for the lack 
of specificity of phospholipid/spectrin binding 
which we report here. Such an interaction was 
previously ruled out, on the grounds that spectrin 
does not affect the phase transition of pure DMPC 
or DMPE monolayers, whereas it modifies the 
transition of pure DMPS or DMPS : DMPE 1: 1 
monolayers [7]. However, the temperature of the 
gel-liquid crystalline phase transition for zwit- 
terionic lipids is determined by hydrophobic in- 
teractions between the acyl chains, while an 
additional electrostatic effect on the phase transi- 
tion is observed when the lipids are charged [28]. 
A purely superficial dipolar interaction with the 
phospholipid polar heads accounting for the non- 
specific spectrin-lipid binding, would modify only 
the electrostatic component of the phase transi- 
tion, and would thus be more efficient in changing 
the DMPS phase transition compared with that of 
DMPC or of a DMPS:DMPC 1: 1 mixture. A 
selective effect of spectrin on the DMPS phase 
The lineshapes of both phosphorus and 
deuterium spectra in pure lipid mixtures of 
DMPC : DMPS 1: 1 do not correspond to what one 
would expect from an isotropically oriented 
bilayer. The 90” edge lines are enhanced, whereas 
the 0” shoulder has almost disappeared. Similar 
characteristics have been reported with other mix- 
tures including charged lipids, such as POPE- 
POPG [38], and they were attributed to partial 
orientation of the bilayers in the magnetic field. It 
was otherwise suggested [21] that addition of a 
positively charged polypeptide could have a screen- 
ing effect upon the negatively charged bilayers, 
leading to a partial dehydratation and to transition 
from unilamellar [39,40] to multilamellar 
liposomes. Here, the same effect was obtained 
with spectrin, a protein with overall negative 
charge. 
The results of the present NMR study indicate 
that the interaction of spectrin with PS in mixed 
bilayers with zwitterionic lipid is weak and non- 
specific, supporting the conclusion that spectrin is 
unlikely to play a major role in maintaining 
phospholipid asymmetry in red blood cells. This is 
consistent with previous results which show that 
spectrin interacts only loosely with the cytoplasmic 
face of the erythrocyte membrane [41] and with the 
demonstration that heat-induced spectrin-depleted 
vesicles are able to establish and to maintain lipid 
asymmetry to the same extent as erythrocytes 
themselves [42]. 
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